Background: There are no guidelines for antithrombotic therapy on admission to hospice care. Antithrombotic therapy may offer some benefit in these patients, but is also associated with well-described risks.
Objective: We quantified the frequency and characteristics of patients prescribed antithrombotic therapy on discharge from acute care to hospice care.
Design: Retrospective cohort study.
Settings/Subjects: Adult (age>=21 years) patients discharged from acute care to hospice care between January 1, 2010 and June 30, 2014.
Measures: Our primary outcome of interest was receiving an outpatient prescription for antithrombotic therapy on discharge to hospice care.
Dataset creation and analysis code, protocol
Qualitative portion available by request at https://doi.org/10.5064/F69JKYSS.